Evidence map›Paper›PMID 22661534›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2012

Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.

Thomas S C Ng, James R Bading, Ryan Park, Hargun Sohi, Daniel Procissi, David Colcher, Peter S Conti, Simon R Cherry, Andrew A Raubitschek, Russell E Jacobs

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biomedical optics express · 2017
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Thomas S C NgBiological Imaging Center, Beckman Institute, California Institute of Technology, Pasadena, CA, USA.
James R Bading
Ryan Park
Hargun Sohi
Daniel Procissi
David Colcher
Peter S Conti
Simon R Cherry
Andrew A Raubitschek
Russell E Jacobs
California Institute of Technology · USCity Of Hope National Medical Center · USImaging Center · USUniversity of Southern California · USBeckman Research InstituteUniversity of California, Davis · US

Funding

Multimodal mPET &mMRI Imaging InstrumentationR01EB000993 · NIBIB · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI CHERRY, SIMON R, JACOBS, RUSSELL E · 2004 to 2013
$9.2M
SMALL ANIMAL PET SCANNER FOR CANCER APPLICATIONSS10RR015703 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, PETER S · 2001 to 2001
$496k
Micro Computerized Tomography Imaging SystemS10RR019253 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, PETER S · 2004 to 2004
$378k
NCRR NIH HHS S10 RR015703NCRR NIH HHS S10 RR019253NIBIB NIH HHS R01 EB000993
6 · The paper itself

Abstract

unlabelledNoninvasive methods are needed to explore the heterogeneous tumor microenvironment and its modulation by therapy. Hybrid PET/MRI systems are being developed for small-animal and clinical use. The advantage of these integrated systems depends on their ability to provide MR images that are spatially coincident with simultaneously acquired PET images, allowing combined functional MRI and PET studies of intratissue heterogeneity. Although much effort has been devoted to developing this new technology, the issue of quantitative and spatial fidelity of PET images from hybrid PET/MRI systems to the tissues imaged has received little attention. Here, we evaluated the ability of a first-generation, small-animal MRI-compatible PET scanner to accurately depict heterogeneous patterns of radiotracer uptake in tumors.

methodsQuantitative imaging characteristics of the MRI-compatible PET (PET/MRI) scanner were evaluated with phantoms using calibration coefficients derived from a mouse-sized linearity phantom. PET performance was compared with a commercial small-animal PET system and autoradiography in tumor-bearing mice. Pixel and structure-based similarity metrics were used to evaluate image concordance among modalities. Feasibility of simultaneous PET/MRI functional imaging of tumors was explored by following (64)Cu-labeled antibody uptake in relation to diffusion MRI using cooccurrence matrix analysis.

resultsThe PET/MRI scanner showed stable and linear response. Activity concentration recovery values (measured and true activity concentration) calculated for 4-mm-diameter rods within linearity and uniform activity rod phantoms were near unity (0.97 ± 0.06 and 1.03 ± 0.03, respectively). Intratumoral uptake patterns for both (18)F-FDG and a (64)Cu-antibody acquired using the PET/MRI scanner and small-animal PET were highly correlated with autoradiography (r > 0.99) and with each other (r = 0.97 ± 0.01). On the basis of these data, we performed a preliminary study comparing diffusion MRI and radiolabeled antibody uptake patterns over time and visualized movement of antibodies from the vascular space into the tumor mass.

conclusionThe MRI-compatible PET scanner provided tumor images that were quantitatively accurate and spatially concordant with autoradiography and the small-animal PET examination. Cooccurrence matrix approaches enabled effective analysis of multimodal image sets. These observations confirm the ability of the current simultaneous PET/MRI system to provide accurate observations of intratumoral function and serve as a benchmark for future evaluations of hybrid instrumentation.

Indexed as

AlgorithmsAnimalsAntibodiesAutoradiographyCalibrationCopper RadioisotopesFluorodeoxyglucose F18Image Processing, Computer-AssistedMagnetic Resonance ImagingMiceMice, Inbred C57BLNeoplasmsPhantoms, ImagingPositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsAntibodiesCopper RadioisotopesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID22661534
PMCPMC3552656
OpenAlexW2132669775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.